Polar Capital Holdings Plc

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1837309 London, X0

Position in MDGL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$151,445,105

-$5,874,628 QoQ

Shares Held

289,310

+7.1% QoQ

Ownership

1.25%

of shares outstanding

% of Portfolio

0.69%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Polar Capital Holdings Plc holds $3,129,351,296 across 43 Biotechnology names. MDGL ranks #5 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	XENE	Xenon Pharmaceuticals Inc.	4,405,312	$256,168,892
2	ELVN	Enliven Therapeutics, Inc.	5,065,933	$198,584,573
3	NUVL	Nuvalent, Inc.	1,831,253	$187,611,869
4	BBIO	BridgeBio Pharma, Inc.	2,519,306	$187,083,663
5	MDGL	Madrigal Pharmaceuticals, Inc. This page	289,310	$151,445,105
6	ASND	Ascendis Pharma A/S	651,712	$149,066,085
7	REGN	Regeneron Pharmaceuticals, Inc.	192,546	$148,768,741
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,615,586	$140,507,514

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$151,445,105	289,310	+7.1%	Shares	Defined	2026-05-15
2025-12-31	$157,319,733	270,151	+1.9%	Shares	Defined	2026-02-17
2025-09-30	$121,615,533	265,154	+17.6%	Shares	Defined	2025-11-14
2025-06-30	$68,218,082	225,410	+50.1%	Shares	Defined	2025-08-14
2025-03-31	$49,757,370	150,220	+9.1%	Shares	Defined	2025-05-15
2024-12-31	$42,496,260	137,720	+37.1%	Shares	Defined	2025-02-14
2024-09-30	$21,322,804	100,475	-19.8%	Shares	Defined	2024-11-14
2024-06-30	$35,104,048	125,300	+0.1%	Shares	Defined	2024-08-14
2024-03-31	$33,434,743	125,205	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.